Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion.
Julie CharpentierFrancois BriandBenjamin LelouvierFlorence ServantVincent AzalbertAnthony PuelJeffrey E ChristensenAurélie WagetMaxime BranchereauCéline GarretJérome LluchChristophe HeymesEmmanuel BrousseauRemy BurcelinLaurence GuzylackThierry SulpiceEstelle GrassetPublished in: Acta diabetologica (2021)
Altogether, our result demonstrated first the influence of liraglutide on gut microbiota and the intestinal immune system which could at least in part control glucose-induced insulin secretion.